Revenue earned during the period relating to collaboration arrangement.

No definition available.

Name:	qure_CollaborationRevenue
Namespace Prefix:	qure_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The percentage of costs that counterparty has agreed to pay, and for which the reporting entity recognizes as collaboration revenue.

+ References

No definition available.

+ Details

Name:	qure_CollaborativeArrangementCostSharingPercentage
Namespace Prefix:	qure_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated percentage of sales by the counterparty that is expected to be retained by the reporting entity, net of manufacturing costs, third-party royalties, and related amounts.

+ References

No definition available.

+ Details

Name:	qure_EstimatedPercentageOfSalesByCounterpartyToBeRetainedByReportingEntity
Namespace Prefix:	qure_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The royalty percentage receivable by the reporting entity under the license agreement.

+ References

No definition available.

+ Details

Name:	qure_LicenseAgreementRoyaltiesPercentageReceivable
Namespace Prefix:	qure_
Data Type:	us-types:durationStringItemType
Balance Type:	na
Period Type:	duration

- Definition

The up-front payment received as of the effective date of the collaboration agreement,

+ References

No definition available.

+ Details

Name:	qure_UpfrontPaymentReceived
Namespace Prefix:	qure_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_LicensesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_SalesRevenueGoodsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_CounterpartyNameAxis=qure_ChiesiFarmaceuticaiS.p.aMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=qure_CollaborativeArrangementRevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=qure_CollaborativeArrangementLicenseRevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Collaboration arrangements and concentration of credit risk - Chiesi (Details) $ in Thousands, € in Millions			12 Months Ended
	Jun. 30, 2013 EUR (€)	Jun. 30, 2013 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Collaboration arrangements
Collaboration revenues			$ 7,164
License revenues			975
Chiesi Farmaceuticai S.p.A
Collaboration arrangements
Revenues from product sales			0	$ 300	$ 0
Collaborative revenue \| Chiesi Farmaceuticai S.p.A
Collaboration arrangements
Collaboration revenues			$ 7,200	4,900	5,000
Percentage of costs to be paid by counterparty			50.00%
Royalties percentage receivable			mid double digit
Collaborative revenue \| Chiesi Farmaceuticai S.p.A \| Minimum
Collaboration arrangements
Estimated percentage of sales by counterparty to be retained by reporting entity			25.00%
Collaborative revenue \| Chiesi Farmaceuticai S.p.A \| Maximum
Collaboration arrangements
Estimated percentage of sales by counterparty to be retained by reporting entity			35.00%
License revenue \| Chiesi Farmaceuticai S.p.A
Collaboration arrangements
Up-front payment received	€ 17.0	$ 22,100
License revenues			$ 1,000	$ 1,000	$ 1,200